High triglycerides, low HDL cholesterol, and small LDL particles predict incident type 2 diabetes in non-diabetic coronary patients - Abstracts

被引：0
|
作者：
不详
机构：
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2005年 / 117卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A15 / A22
页数：8
相关论文
共 50 条
  • [31] Serum paroxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in type 2 diabetic and non-diabetic subjects
    Dullaart, R. P. F.
    Otvos, J. D.
    James, R. W.
    DIABETOLOGIA, 2014, 57 : S531 - S531
  • [32] A Prospective, Multicentric Study to Evaluate the Effects of Saroglitazar on Non-HDL Cholesterol and Small Dense LDL Particles in Patients with Diabetic Dyslipidemia
    Kaul, Upendra
    Jain, Peeyush
    Kachru, Ranjan
    Bhatia, Vineet
    Arambam, Priyadarshini
    Shekhawat, Sudhir
    Diana, Yumnam
    Rawat, Kavita
    Singh, Shilpi
    Jaiswal, Ashok
    DIABETES, 2018, 67
  • [33] Both LDL Cholesterol and LDL Particles Associated with MACE in Tibetan Patients with Type 2 Diabetes
    Zhang, Chenghui
    Wang Suyuan
    Li, Mingxia
    DIABETES, 2024, 73
  • [34] Albuminuria is associated with coronary atherosclerosis both in patients with type 2 diabetes and in non-diabetic individuals
    Rein, P.
    Boehnel, C.
    Saely, C. H.
    Vonbank, A.
    Beer, S.
    Jankovic, V.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 75 - 75
  • [35] Conversion of type B to type a LDL-cholesterol with pioglitazone in non-diabetic patients: Initial clinical observations
    Feinstein, S.
    Arnsdorf, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 69 - 69
  • [36] Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
    Munoz-Hernandez, Liliana
    Ortiz-Bautista, Raul J.
    Brito-Cordova, Griselda
    Lozano-Arvizu, Francisco
    Saucedo, Sharim
    Perez-Mendez, Oscar
    Zentella-Dehesa, Alejandro
    Dauteuille, Carolane
    Lhomme, Marie
    Lesnik, Philippe
    Chapman, M. John
    Kontush, Anatol
    Aguilar Salinas, Carlos A.
    ATHEROSCLEROSIS, 2018, 277 : 72 - 79
  • [37] Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus
    Klisic, A.
    Kavaric, N.
    Vujcic, S.
    Mihajlovic, M.
    Zeljkovic, A.
    Ivanisevic, J.
    Spasojevic-Kalimanovska, V
    Ninic, A.
    Kotur-Stevuljevic, J.
    Vekic, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8127 - 8135
  • [38] Influence of BMI and HbA1c on cardiovascular risk factors: LDL cholesterol and non HDL cholesterol in type 2 diabetic patients
    Disoteo, O.
    Pizzi, G. L.
    Zanni, D.
    Fossati, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 114 - 114
  • [39] TRIGLYCERIDES/HDL-CHOLESTEROL RATIO IS CORRELATED WITH INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Tjokroprawiro, A.
    Suryantoro, S. Dwi
    Murtiwi, S.
    Sutjahjo, A.
    Wibisono, S.
    Pranoto, A.
    Adi, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S91 - S92
  • [40] Coronary heart disease in patients with low LDL-cholesterol - Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors
    Sacks, FM
    Tonkin, AM
    Craven, T
    Pfeffer, MA
    Shepherd, J
    Keech, A
    Furberg, CD
    Braunwald, E
    CIRCULATION, 2002, 105 (12) : 1424 - 1428
12345